JAKARTA – Enovid’s antiviral nasal spray, developed in Canada and tested in the UK, is believed to reduce viral load in confirmed cases of COVID-19 by 95 percent within 24 hours and 99 percent within 72 hours, the company said on Sunday July 11.
Israeli-style sprays can be used up to five times a day after contact with the virus, the statement said. It is suitable for 12-year-olds and the Ministry of Health approved it in January of this year. It will go on sale next week.
“The spray we developed has proven not only as a deterrent against the virus that causes COVID-19, but also as a killer,” said Dr Gili Regev, CEO and founder of Snotize, the company who developed the spray.
Since most COVID-19 infections are from the nose, SaNOtize believes this is an effective way to reduce the spread and infection of COVID-19. He was able to suppress the SARS-CoV-2 virus within two minutes, including alpha and gamma variants, the statement said. This spray is tested against the delta variants.
The spray uses nitric oxide as a mechanical and chemical barrier against viral infections in the nose, where respiratory illnesses such as COVID-19 infiltrate the body. The spray is also effective against other respiratory viruses such as those that cause the flu.
Earlier, citing Reuters on March 22, SaNOtize and Ashford and St Peter’s Hospitals NHS Foundation Trust in Surrey, UK, announced the results of a clinical trial showing that nitric oxide nasal spray (NONS) is a treatment effective antiviral, can prevent the transmission of COVID-19, shorten its course and reduce the severity of symptoms and damage in people already infected.
“The formulation of nitric oxide used in humans is designed to” kill the virus in the upper respiratory tract, preventing it from inducing and spreading to the lungs, “said Chris Miller, scientific director of sanOtize.
The English, Chinese, Japanese, Arabic, French, and Spanish versions are automatically generated by the system. So there may still be inaccuracies in translating, please always see Indonesian as our main language. (system supported by DigitalSiber.id)
– .
